Predicta Biosciences

Developer of an oncology technology platform designed for cancer diagnosis and treatment. The company's platform specializes in integrating multi-omics and liquid biopsy technologies with non-invasive...

Healthcare

Cambridge, MA, United States

Founded 2023

11 employees

Website

Valuation

$49M

Market implied

Share Price

N/A

Total Raised

$29.2M

Last Round

N/A

Investors

+12 other investors

View all 12 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Predicta Biosciences's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required